About the Program
What is Sunshine Genetics?
The Sunshine Genetics Program is a voluntary research program using whole-genome sequencing (WGS) as an additional newborn screening tool. This genomic newborn screening program can help identify certain rare, actionable genetic conditions earlier in life, offering families the choice to learn additional information about their child that can empower them to plan next steps sooner.
Participation is voluntary and separate from standard newborn screening.
Families choose to enroll and can withdraw at any time.
4-5 Years
It often takes atleast 4-5 years for a child to be diagnosed with a rare disease.
1 in 10
10% of Americans are affected by rare diseases.
80%
80% of pediatric rare diseases are genetic.
~600
600 rare diseases have potential interventions when detected early.
Our Mission
Our mission is to enable earlier identification of genetic conditions so that children and families can benefit from timely care, support, and informed decision-making.
Our Purpose
Sunshine Genetics aims to evaluate the feasibility and the ethical, psychosocial and health economic impact of genomic newborn screening to inform decisions about future genomic newborn screening implementation in Florida.
Why this Work Matters
Early Detection Saves Time
Early detection allows families and providers to intervene in a timely fashion.
Better Health Outcomes
Identifying conditions early can lead to improved health outcomes in the long-term.
Support for Families
Families receive guidance, education, and access to specialists when needed.
Advancing Research
This program contributes to the future of genomic newborn screening and pediatric healthcare.
How Sunshine Genetics is Different
Standard Newborn Screening
- Screens for ~60 childhood onset conditions
- Conducted for all newborns
- Uses biochemical screening
VS
Sunshine Genetics
- Screens for 900+ childhood onset conditions
- A voluntary, no-cost program for Florida newborns
- Uses whole genome sequencing
Participation is optional, free of charge, and does not replace standard newborn screening.
Research & Scientific Background
Sunshine Genetics is based on advances in genomic sequencing, which allows researchers to analyze a broader set of genetic conditions than traditional screening methods.
This research study is designed to evaluate how genomic newborn screening can be safely, effectively, and responsibly introduced into clinical care.
All findings are reviewed by qualified experts, including genetic counselors, before results are shared with families.
Who is involved
Sunshine Genetics is developed in collaboration with leading researchers, clinicians, and institutions focused on pediatric health and rare disease research.
Explore the Conditions We Screen For
The program focuses on identifying medically actionable genetic conditions—conditions where early detection can lead to meaningful care or intervention.
Families can explore the types of conditions included and learn how early screening can make a difference.
Sunshine genetics uses a two-tiered screening framework. Families can opt into receiving screening for Tier 1 conditions or Tier 1 + Tier 2 condition.
Ready to Take the Next Step?
If your newborn is eligible, you can take part in Sunshine Genetics to access early screening and contribute to important research.